Previous 10 | Next 10 |
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Buy rating and $69 (55% upside) price target at Citigroup. More news on: ACADIA Pharmaceuticals Inc., Alector, Inc., GW Pharmaceuticals plc, Healthcare stocks news, , Stocks on the move, Read more ...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 5, 2020 at 8:30 a.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2019. A press release detailing these results will be issued prior t...
Contracted Acres for 2020 Triples 2019 Planted Acreage Footprint to Support Growing Demand for Calyxt High Oleic Soybean Oil First Purchase Order for HO Soybean Oil in Industrial Segment from New Customer Operating in All Four of Calyxt’s Premium Oil Target Markets Calyxt...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has appointed Bobby Williams, Ph.D. to the newly created role of Director of Gene Editing to further expand Calyxt’s innovation, product pipeline, and trait discovery efforts and inform product advancement decisions. ...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has released the following letter to its stockholders from Jim Blome, Chief Executive Officer. Dear Fellow Stockholders: 2019 was an exciting year as we achieved several operational mi...
The word "biotech" often gets used interchangeably with "biopharma," but that's not quite correct. Biopharmaceuticals are just one part of the broader sector, which also includes agricultural biotech, industrial biotech, and several other subsectors. It's an important distinction for investors t...
New Collaboration Expands Calyxt’s Access to Geographies with 45% of Domestic Soybean Acreage & Helps Support Future Launch of High Fiber Wheat Product in Four of Top Ten Wheat Production States Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healt...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Gainers: Audentes Therapeutics (NASDAQ: BOLD ) +105% . More news on: Audentes Therapeutics, Inc., ViewRay, Inc., Outlook Therapeutics, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...